tiprankstipranks
Trending News
More News >
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8
Germany Market

BioMarin Pharmaceutical (BM8) Cash flow

Compare
1 Followers

BioMarin Pharmaceutical Cash Flow

DE:BM8's free cash flow for Q4 2025 was $58.92M. For the 2025 fiscal year, DE:BM8's free cash flow was decreased by $249.53M and operating cash flow was $99.64M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ 827.99M$ 572.84M$ 159.26M$ 175.90M$ 304.54M
Investing Cash Flow
$ -414.24M$ 136.49M$ -111.24M$ -20.03M$ -366.31M
Financing Cash Flow
$ -42.39M$ -526.45M$ -18.73M$ -18.65M$ -48.00K
End Cash Position
$ 1.31B$ 942.84M$ 755.13M$ 724.53M$ 587.28M
Free Cash Flow
$ 724.96M$ 475.42M$ 62.57M$ 54.94M$ 185.31M
Currency in USD

BioMarin Pharmaceutical Cash Flow